@article{PMID:23168367, author = {Schmitz, N. and Nickelsen, M. and Ziepert, M. and Haenel, M. and Borchmann, P. and Schmidt, C. and Viardot, A. and Bentz, M. and Peter, N. and Ehninger, G. and Doelken, G. and Ruebe, C. and Truemper, L. and Rosenwald, A. and Pfreundschuh, M. and Loeffler, M. and Glass, B.}, title = {Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1).}, journal = {Lancet Oncol}, year = {2012}, volume = {13}, number = {12}, pages = {1250--1259}, url = {http://www.ncbi.nlm.nih.gov/pubmed/23168367}, }